oral semaglutide brand name india title Today we launch, Obeda®, India's first DCGI-approved generic injection for Type 2 Diabetes. This product reinforces our purpose of good health cant wait, to bring high quality and affordable treatment Why Sun Pharma's semaglutide approval

Once you stop injecting or taking semaglutide orally, your body no longer receives these signals, and appetite typically returns to baseline levels

Good idea that needs further refinement

Hanmi Pharmaceutical is also preparing to commercialize its self-developed GLP-1based obesity treatment efpeglenatide and is pursuing regulatory procedures with the aim of launching the drug as early as the second half of this year

These agents mimic the bodys natural glucagon-like peptide-1 hormone, regulating blood glucose while promoting satiety and weight loss

These products are not approved for cosmetic weight loss and should only be used under the supervision of a licensed healthcare provider